Taking a step back from testing: Preanalytical considerations in molecular infectious disease diagnostics

被引:3
|
作者
Conrad, Stephanie [1 ]
Kanegusuku, Anastasia Gant [2 ]
Conklin, Steven E. [1 ,3 ]
机构
[1] Tufts Med Ctr, Dept Pathol & Lab Med, Boston, MA 19716 USA
[2] Univ Chicago, Dept Pathol, Chicago, IL USA
[3] Tufts Univ, Dept Anat & Clin Pathol, Sch Med, Boston, MA 19716 USA
关键词
Preanalytics; Molecular diagnostics; Infectious disease; POLYMERASE CHAIN-REACTION; NUCLEIC-ACID; ANTIRETROVIRAL THERAPY; TRANSPORT MEDIA; PCR INHIBITORS; WHOLE-BLOOD; STORAGE; STABILITY; DNA; SPECIMEN;
D O I
10.1016/j.clinbiochem.2022.12.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Recent studies evaluating the preanalytical factors that impact the outcome of nucleic-acid based methods for the confirmation of SARS-CoV-2 have illuminated the importance of identifying variables that promoted accurate testing, while using scarce resources efficiently. The majority of laboratory errors occur in the preanalytical phase. While there are many resources identifying and describing mechanisms for main laboratory testing on automated platforms, there are fewer comprehensive resources for understanding important preanalytical and environmental factors that affect accurate molecular diagnostic testing of infectious diseases. This review identifies evidence-based factors that have been documented to impact the outcome of nucleic acid-based molecular techniques for the diagnosis of infectious diseases.
引用
收藏
页码:22 / 32
页数:11
相关论文
共 50 条
  • [31] Molecular characterization of an Infectious bursal disease virus isolate from Iran
    Hosseini, SD
    Omar, AR
    Aini, I
    ACTA VIROLOGICA, 2004, 48 (02) : 79 - 83
  • [32] Taking a step back for a leap forward: policy formation for the digitalisation of schools from the views of Swedish national policymakers
    Gustafsson, Ulrika
    EDUCATION INQUIRY, 2021, 12 (04) : 329 - 346
  • [33] Testing for equine infectious anemia (Reprinted from Equine Disease Quarterly, vol 7)
    不详
    EQUINE PRACTICE, 1999, 21 (06): : 13 - 13
  • [34] SEROLOGICAL TESTING IN A MICROBIOLOGY LABORATORY OF SPECIMENS FROM PATIENTS WITH SUSPECTED INFECTIOUS-DISEASE
    WAGHORN, DJ
    JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (04) : 358 - 363
  • [35] EFFECT OF DRAWING SAMPLES FOR INFECTIOUS-DISEASE TESTING FROM TUBING OF THE PRIMARY CONTAINER
    AUBUCHON, JP
    FANG, C
    MCCURDY, K
    ZIMMERMAN, B
    FOREY, JE
    COBURN, TJ
    TRANSFUSION, 1987, 27 (06) : 524 - 524
  • [36] Molecular characterization of field infectious bursal disease virus isolates from Nigeria
    Nwagbo, Ijeoma O.
    Shittu, Ismaila
    Nwosuh, Chika I.
    Ezeifeka, George O.
    Odibo, Frederick J. C.
    Michel, Linda O.
    Jackwood, Daral J.
    VETERINARY WORLD, 2016, 9 (12) : 1420 - 1428
  • [37] Molecular characterization of recent infectious bursal disease virus isolates from Malaysia
    Nurulfiza, I.
    Hair-Bejo, M.
    Omar, A. R.
    Aini, I.
    ACTA VIROLOGICA, 2006, 50 (01) : 45 - 51
  • [38] Real-life impact on antimicrobial prescription of Syndromic Molecular Testing in adults hospitalized in infectious disease departments. Respiratory Syndromic Molecular Testing panel: Is it worth it?
    Clauss, Severine
    Bourlet, Stephane
    Jaffal, Karim
    Duran, Clara
    D'Anglejan, Emma
    Perronne, Veronique
    Bouchand, Frederique
    Noussair, Latifa
    Dahmane, Lotfi
    Dinh, Aurelien
    INFECTIOUS DISEASES NOW, 2024, 54 (05):
  • [39] New Foci for the Genetic Testing Reference Material (GeT-RM) Program: Molecular Oncology and Infectious Disease
    Barker, S.
    Bossler, A. D.
    Schneider, E.
    Kalman, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 597 - 597
  • [40] DNA repair and neurological disease: From molecular understanding to the development of diagnostics and model organisms
    Abugable, Arwa A.
    Morris, Julia L. M.
    Palminha, Nelma M.
    Zaksauskaite, Ringaile
    Ray, Swagat
    E-Khamisy, Sherif F.
    DNA REPAIR, 2019, 81